Drugs and Money
Pharmaceutical companies, academic medicine, and the flow of funds and favors

Reviewing conflict-of-interest policies

Funds flowing in

"We accept money because we need to do clinical trials, and that's where the rubber meets the road in this conflict-of-interest business."

"I'm not under any illusion that [drug companies] give money for the sake of neuroscience. They won't do a study if the potential is there for the outcome to have a negative impact on marketing."


THE INTELLECTUAL COMMUNITY

Bringing the Big Questions to the Community
Re-imagining the Gustafson Seminar

Multiversity or University?
Pursuing competing goods simultaneously


Uprooted
On the failure of roots and the strength of weak ties


Endnotes

Search this Site       GOOGLE.com      


What's New


Voices in This Issue

Peter Block, Cardiology and Internal Medicine
J. Douglas Bremner, Psychiatry and Radiology
Nassir Ghaemi, Psychiatry and Public Health
Regine O. Jackson, Graduate Institute of the Liberal Arts
Howard Kushner, Graduate Institute of the Liberal Arts and Public Health
Thomas Lawley, Dean,
Medical School

Leslie Real, Biology
Don Stein, Emergency Medicine
James W. Wagner, President


Emory Faculty Books


Emory University Home Page

Search Emory

Copyright @Emory University
Atlanta, GA 2007

Feb/Mar 07
Vol 9 No 4